Novel delivery approaches for cancer therapeutics-Reference-Cited by-同舟云学术

Novel delivery approaches for cancer therapeutics

Published:2015-12 Issue: Volume:219 Page:248-268
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Mitra Ashim K.,Agrahari Vibhuti,Mandal Abhirup,Cholkar Kishore,Natarajan Chandramouli,Shah Sujay,Joseph Mary,Trinh Hoang M.,Vaishya Ravi,Yang Xiaoyan,Hao Yi,Khurana Varun,Pal Dhananjay

Funder

University of Kansas Cancer Center and NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference361 articles.

1. pH-sensitive nano-systems for drug delivery in cancer therapy;Liu;Biotechnol. Adv.,2014

2. Enzyme-responsive nanoparticles for drug release and diagnostics;de la Rica;Adv. Drug Deliv. Rev.,2012

3. Cancer treatment and survivorship statistics;DeSantis;CA Cancer J. Clin.,2014

4. The hallmarks of cancer;Hanahan;Cell,2000

5. Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases;Talekar;AAPS J.,2015

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug delivery systems in colorectal cancer: Advances and future prospects;Pathology - Research and Practice;2024-10

2. Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy;Current Pharmaceutical Design;2024-10

3. Identification of dual inhibitors for EGFR(T790M/C797S) and VEGFR-2 in Non-Small Cell Lung Cancer from Moringa oleifera derived phytochemicals: An In-silico Approach;2024-04-23

4. Phytosomes: a critical tool for delivery of herbal drugs for cancer;Phytochemistry Reviews;2024-04-04

5. An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction;Nature Communications;2024-04-02